Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinomaOmkara Veeranki, Dipen M. Maru|Oncotarget|2019Cited by 13